MacroGenics Updates Corporate Presentation With Clinical Program Details
at www.tipranks.com (Fri, 13-Nov 5:48 PM)
at www.tipranks.com (Fri, 13-Nov 12:50 PM)
Stifel Nicolaus Sticks to Its Hold Rating for MacroGenics (MGNX)
at www.tipranks.com (Fri, 13-Nov 9:05 AM)
MacroGenics GAAP EPS of -$0.32 misses by $0.28, revenue of $18.67M misses by $20.51M
at seekingalpha.com (Thu, 12-Nov 4:39 PM)
MacroGenics spotlights a 25% response signal for lorigerlimab in clear cell gynecologic cancer
Market Chameleon (Tue, 27-Oct 11:39 AM)